China NMPA Inspection - Huai'an Jiaheng Cosmetics Co., Ltd. - December 31, 2020

On December 31, 2020, the National Medical Products Administration (NMPA) published findings from an unannounced inspection of Huaian Jiaheng Cosmetics Co., Ltd. The inspection, conducted by the NMPA Drug Inspection and Testing Center and the Jiangsu Provincial Drug Administration, revealed significant non-compliance with the *Key Points for Cosmetic Production License Inspection*. Key issues identified included deficiencies in staff competence and inconsistent sample management within the quality control system. The facility also exhibited improper storage of raw materials and lacked essential cleaning and disinfection records for equipment. Furthermore, the company failed to maintain adequate sample retention for materials and finished products, and critical batch production records were found to be incomplete. As a result, the Jiangsu Provincial Drug Administration has mandated that Huaian Jiaheng Cosmetics Co., Ltd. implement corrective actions for all identified deficiencies within a specified timeframe. The company is also required to submit a report detailing these rectifications to the Cosmetic Supervision Department of the NMPA within two months from the date of the order. This action underscores the regulatory commitment to ensuring product quality and safety within the cosmetics industry.